Pub. Date : 2022 Mar
PMID : 35098414
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | To enhance the declined level of acetylcholine (ACh) resulting from loss of cholinergic neurons, acetylcholinesterase (AChE) inhibitors are developed and successfully approved for AD treatment in the clinic, with a limited therapeutic effectiveness. | Acetylcholine | acetylcholinesterase (Cartwright blood group) | Homo sapiens |
| 2 | To enhance the declined level of acetylcholine (ACh) resulting from loss of cholinergic neurons, acetylcholinesterase (AChE) inhibitors are developed and successfully approved for AD treatment in the clinic, with a limited therapeutic effectiveness. | Acetylcholine | acetylcholinesterase (Cartwright blood group) | Homo sapiens |
| 3 | To enhance the declined level of acetylcholine (ACh) resulting from loss of cholinergic neurons, acetylcholinesterase (AChE) inhibitors are developed and successfully approved for AD treatment in the clinic, with a limited therapeutic effectiveness. | Acetylcholine | acetylcholinesterase (Cartwright blood group) | Homo sapiens |
| 4 | To enhance the declined level of acetylcholine (ACh) resulting from loss of cholinergic neurons, acetylcholinesterase (AChE) inhibitors are developed and successfully approved for AD treatment in the clinic, with a limited therapeutic effectiveness. | Acetylcholine | acetylcholinesterase (Cartwright blood group) | Homo sapiens |